Use of doxycycline for the prevention of bacterial sexually transmitted infections (STIs) (DoxyPEP)

The increasing incidence of bacterial sexually transmitted infections (STIs), particularly among men having sex with men has encouraged the wide preventative use of doxycycline as Post-Exposure Prophylaxis (DoxyPEP), although experts think the strategy could benefit patients outside this group.
There are also concerns associated with antimicrobial resistance and the frequent (and potentially incorrect) use of antibiotics by individuals who use this intervention. This event will inform pharmacists of the evidence supporting the rational use of this intervention and explore the potential impacts of widespread use from a public health perspective.
Moderator:
Darija Kuruc Poje, Hospital pharmacist - Vice-president EAHP
EAHP - European association of hospital pharmacists, Croatia
Co-Moderator:
Ria Benko, Chief pharmacist University of Szeged, Hungary
Panellists:
Laura Bachmann, Chief Medical Officer Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Division of STD Prevention, United States
Thibaut Vanbaelen, Medical Doctor and Researcher Institute of Tropical Medicine, Antwerp, Belgium
Fabian Kong, Deputy Head, Sexual Health Unit Centre for Epidemiology and Biostatistics Melbourne School of Population and Global Health The University of Melbourne, Australia